FDA
approval
· 2023-04-18
FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Aurobindo Pharma Limited)
Summary
The FDA approved a supplemental application for Abacavir/lamivudine from Aurobindo Pharma Limited, enabling the marketing of this generic fixed-dose combination…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)